News
Interim Phase 3 Results Support Ovaprene's Differentiation as a First-in-Category, Hormone-Free, Intravaginal Monthly ContraceptiveSAN DIEG ...
Despite the increasing risks of war, unpredictable weather and economic shocks to food security, only 30 countries are ...
TORONTO, ON / ACCESS Newswire / July 14, 2025 /Jaguar Mining Inc. ("Jaguar" or the "Company") (TSX:JAG) is pleased to announce the successful conclusion of negotiations regarding a significant ...
ESSA Pharma Inc. ("ESSA," or the "Company") (NASDAQ: EPIX) today announced that it has entered into a definitive agreement (the "Business Combination Agreement") with XenoTherapeutics, Inc. ("Xeno"), ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results